Cargando…
An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases
INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far,...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762074/ https://www.ncbi.nlm.nih.gov/pubmed/28875761 http://dx.doi.org/10.1177/1533034617728862 |
_version_ | 1783291629620166656 |
---|---|
author | Kolberg, Hans-Christian Afsah, Shabnam Kuehn, Thorsten Winzer, Ute Akpolat-Basci, Leyla Stephanou, Miltiades Wetzig, Sarah Hoffmann, Oliver Liedtke, Cornelia |
author_facet | Kolberg, Hans-Christian Afsah, Shabnam Kuehn, Thorsten Winzer, Ute Akpolat-Basci, Leyla Stephanou, Miltiades Wetzig, Sarah Hoffmann, Oliver Liedtke, Cornelia |
author_sort | Kolberg, Hans-Christian |
collection | PubMed |
description | INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far, very few protocols with an activity below 20 MBq have been reported. We developed an ultralow-dose 1-day protocol with a mean activity lower than 20 MBq in order to reduce radiation exposure for patients and staff. Here, we are presenting our experiences in 150 consecutive cases. MATERIALS AND METHODS: A total of 150 patients with clinically and sonographically negative axilla and no multicentricity underwent a sentinel lymph node biopsy using an ultralow-dose protocol performed on the day of surgery. No patient received systemic therapy prior to sentinel node biopsy. After peritumoral injection of the tracer Technetium-99m, a lymphoscintigraphy was performed in all cases. Seven minutes before the first cut, we injected 5 mL of blue dye in the region of the areola. RESULTS: In 148 (98.7%) of 150 patients, at least 1 sentinel lymph node could be identified by lymphoscintigraphy; the detection rate during surgery with combined tracers Technetium-99m and blue dye was 100%. The mean applied activity was 17.8 MBq (9-20). A mean number of 1.3 (0-5) sentinel lymph nodes were identified by lymphoscintigraphy and a mean number of 1.8 (1-5) sentinel lymph nodes were removed during sentinel lymph node biopsy. CONCLUSION: Ultralow-dose 1-day protocols with an activity lower than 20 MBq are a safe alternative to 1-day or 2-day protocols with significantly higher radiation doses in primary surgery for early breast cancer. Using Technetium-99m and blue dye in a dual tracer approach, detection rates of 100% are possible in clinical routine in order to reduce radiation exposure for patients and staff. |
format | Online Article Text |
id | pubmed-5762074 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-57620742018-01-17 An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases Kolberg, Hans-Christian Afsah, Shabnam Kuehn, Thorsten Winzer, Ute Akpolat-Basci, Leyla Stephanou, Miltiades Wetzig, Sarah Hoffmann, Oliver Liedtke, Cornelia Technol Cancer Res Treat Original Articles INTRODUCTION: Common protocols for the detection of sentinel lymph nodes in early breast cancer often include the injection of the tracer 1 day before surgery. In order to detect enough activity on the day of surgery, the applied activity in many protocols is as high as several hundred MBq. So far, very few protocols with an activity below 20 MBq have been reported. We developed an ultralow-dose 1-day protocol with a mean activity lower than 20 MBq in order to reduce radiation exposure for patients and staff. Here, we are presenting our experiences in 150 consecutive cases. MATERIALS AND METHODS: A total of 150 patients with clinically and sonographically negative axilla and no multicentricity underwent a sentinel lymph node biopsy using an ultralow-dose protocol performed on the day of surgery. No patient received systemic therapy prior to sentinel node biopsy. After peritumoral injection of the tracer Technetium-99m, a lymphoscintigraphy was performed in all cases. Seven minutes before the first cut, we injected 5 mL of blue dye in the region of the areola. RESULTS: In 148 (98.7%) of 150 patients, at least 1 sentinel lymph node could be identified by lymphoscintigraphy; the detection rate during surgery with combined tracers Technetium-99m and blue dye was 100%. The mean applied activity was 17.8 MBq (9-20). A mean number of 1.3 (0-5) sentinel lymph nodes were identified by lymphoscintigraphy and a mean number of 1.8 (1-5) sentinel lymph nodes were removed during sentinel lymph node biopsy. CONCLUSION: Ultralow-dose 1-day protocols with an activity lower than 20 MBq are a safe alternative to 1-day or 2-day protocols with significantly higher radiation doses in primary surgery for early breast cancer. Using Technetium-99m and blue dye in a dual tracer approach, detection rates of 100% are possible in clinical routine in order to reduce radiation exposure for patients and staff. SAGE Publications 2017-09-06 2017-12 /pmc/articles/PMC5762074/ /pubmed/28875761 http://dx.doi.org/10.1177/1533034617728862 Text en © The Author(s) 2017 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Articles Kolberg, Hans-Christian Afsah, Shabnam Kuehn, Thorsten Winzer, Ute Akpolat-Basci, Leyla Stephanou, Miltiades Wetzig, Sarah Hoffmann, Oliver Liedtke, Cornelia An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title | An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title_full | An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title_fullStr | An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title_full_unstemmed | An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title_short | An Ultralow-Dose 1-Day Protocol With Activities Lower Than 20 MBq for the Detection of Sentinel Lymph Nodes in Breast Cancer—Experiences After 150 Cases |
title_sort | ultralow-dose 1-day protocol with activities lower than 20 mbq for the detection of sentinel lymph nodes in breast cancer—experiences after 150 cases |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762074/ https://www.ncbi.nlm.nih.gov/pubmed/28875761 http://dx.doi.org/10.1177/1533034617728862 |
work_keys_str_mv | AT kolberghanschristian anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT afsahshabnam anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT kuehnthorsten anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT winzerute anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT akpolatbascileyla anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT stephanoumiltiades anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT wetzigsarah anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT hoffmannoliver anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT liedtkecornelia anultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT kolberghanschristian ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT afsahshabnam ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT kuehnthorsten ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT winzerute ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT akpolatbascileyla ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT stephanoumiltiades ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT wetzigsarah ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT hoffmannoliver ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases AT liedtkecornelia ultralowdose1dayprotocolwithactivitieslowerthan20mbqforthedetectionofsentinellymphnodesinbreastcancerexperiencesafter150cases |